Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Nectar

company

About

Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.

Details

Last Funding Type
Series A
Last Funding Money Raised
$16.50M
Industries
Clinical Trials,Health Care,Health Diagnostics,Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2021
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Nectar Life Sciences, Inc.
Also Known As
Nectar Life Sciences

Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research. The company was founded in 2021 and is headquartered in New York.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$24.50M
Nectar has raised a total of $24.50M in funding over 2 rounds. Their latest funding was raised on Dec 20, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 20, 2022 Series A $16.50M 3 Harmony Partners Detail
Mar 16, 2022 Seed $8M 2 Juxtapose Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Nectar is funded by 3 investors. Harmony Partners and Juxtapose are the most recent investors.
Investor Name Lead Investor Funding Round
Harmony Partners Yes Series A
Juxtapose Series A
Obvious Ventures Series A